Global Mucosal Atomization Devices Market Report 2022: A $960 Million Market by 2026 – Forecasts to 2031 Featuring Major Players – Teleflex, DeVilbiss Healthcare, BD and Co, Kurve Therapeutics, Cook – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Mucosal Atomization Devices Global Market Report 2022: Ukraine-Russia War Impact” report has been added to ResearchAndMarkets.com’s offering.

The global mucosal atomization devices market is expected to grow from $0.66 billion in 2021 to $0.71 billion in 2022 at a compound annual growth rate (CAGR) of 7.22%. The mucosal atomization devices market is expected to grow to $0.96 billion in 2026 at a compound annual growth rate (CAGR) of 7.76%.

The main types of mucosal atomization devices include nasal atomization devices, fibre-optic atomization devices, laryngotracheal atomization devices, and bottle atomizer devices. Nasal atomization devices offer a painless, safe approach to giving patients fast-acting drugs that quickly penetrate mucosal membranes and enter the bloodstream.

The different mucosal atomization device technologies include gas propelled atomization devices and electrical atomization devices which are used by end-users including hospitals, ambulatory surgical centres and specialized clinics.

North America was the largest region in the mucosal atomization devices market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mucosal atomization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The increasing prevalence of allergic rhinitis and sinus across the world propels the growth of the mucosal atomization devices market. Allergic rhinitis refers to a range of symptoms that affect the nose and are brought by breathing allergens such as pollen, dust, or animal dander. Sinuses refer to the hollow areas in the bones of the forehead, cheekbones, and between the eyes region and when the tissue lining the sinuses become inflamed or swollen is known as sinusitis.

Mucosal atomization devices are used to provide budesonide as a topical nasal steroid spray in chronic rhinosinusitis treatment. According to the data published by ‘Sinus and Allergy Wellness Centre’, a US-based organization, in the United States, in 2020, sinusitis has impacted 300 million or 11.6% of American adults. Therefore, the increasing prevalence of allergic rhinitis and sinus across the world drives the growth of the mucosal atomization devices market.

The strategic partnerships are key trends gaining popularity in the mucosal atomization devices market. Major companies operating in mucosal atomization devices are undergoing partnerships to strengthen their position in the market. For instance, in October 2021, Pulmodyne Inc, a US-based company that provides drug atomization delivery, partnered with Alcove Manufacturing and Distribution Inc, a UK-based company With this partnership, The EZ-Spray Atomization System will start to be distributed by Pulmodyne through its current channels. The cooperation aims to advance industry innovation in addition to distribution, and this connection will enable the two seasoned businesses to quickly optimize product designs.

In March 2022, Kurve Technology Inc, a US-based company that engaged in the development of liquid drug delivery devices for topical, systemic, and nose-to-brain medical therapies, merged with Savile Therapeutics Inc. This merger allows Kurve Technology to gain access to the assets of Savile Therapeutics Inc and drive further growth and expansion. Savile Therapeutics Inc is a US-based medical device company.

The countries covered in the mucosal atomization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Major players in the mucosal atomization devices market are

Teleflex Incorporated

DeVilbiss Healthcare LLC

Becton Dickinson and Company

Kurve Therapeutics

Cook

Medica Holdings LLC

Life-Assist Inc

MedTree (BTME Group Ltd)

Integra LifeSciences

BVM Meditech Private Limited

Drive Medical

DS Medical

Wolfetory Medical Inc

MILA International

Magal Healthcare Pvt Ltd

Key Topics Covered:

1. Executive Summary

2. Mucosal Atomization Devices Market Characteristics

3. Mucosal Atomization Devices Market Trends And Strategies

4. Mucosal Atomization Devices Market – Macro Economic Scenario

4.1. COVID-19 Impact On Mucosal Atomization Devices Market

4.2. Ukraine-Russia War Impact On Mucosal Atomization Devices Market

4.3. Impact Of High Inflation On Mucosal Atomization Devices Market

5. Mucosal Atomization Devices Market Size And Growth

5.1. Global Mucosal Atomization Devices Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Mucosal Atomization Devices Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Mucosal Atomization Devices Market Segmentation

6.1. Global Mucosal Atomization Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Nasal Atomization Devices

Fiber-Optic Atomization Devices

Laryngo-Tracheal Atomization Devices

Bottle Atomizer Devices

6.2. Global Mucosal Atomization Devices Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Gas Propelled Atomization Devices

Electrical Atomization Devices

6.3. Global Mucosal Atomization Devices Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Hospitals

Ambulatory Surgical Centers

Specialized Clinics

7. Mucosal Atomization Devices Market Regional And Country Analysis

7.1. Global Mucosal Atomization Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Mucosal Atomization Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/6njom7

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.